Lv11
50 积分 2025-03-07 加入
Functional outcomes with esketamine in treatment-resistant depression: A 6-month multicenter real-world study
1个月前
已关闭
Esketamine and Quality of Life Improvement in Treatment-Resistant Depression Patients
1个月前
已完结
Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study
1个月前
已完结
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD
2个月前
已完结
Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial
2个月前
已完结
Gepirone Extended-Release in the Treatment of Adult Outpatients With Major Depressive Disorder
2个月前
已完结
Semaglutide for the treatment of cognitive dysfunction in major depressive disorder: A randomized clinical trial
3个月前
已完结
A phase II, randomized, double-blinded, placebo-controlled trial of liraglutide in Parkinson's disease
3个月前
已完结
Histamine receptors, agonists, and antagonists in health and disease
3个月前
已关闭
[Clinical study on malnutrition and low take of protein and energy in peritoneal dialysis patients]
皖公网安备34019202002308
